June 15, 2020 / 12:14 PM / 2 months ago

BRIEF-Applied Therapeutics Announces Start Of At-007 Pediatric Galactosemia Study

June 15 (Reuters) - Applied Therapeutics Inc:

* APPLIED THERAPEUTICS ANNOUNCES START OF AT-007 PEDIATRIC GALACTOSEMIA STUDY; RELEASES ADDITIONAL 40MG/KG DATA FROM ADULT GALACTOSEMIA STUDY

* APPLIED THERAPEUTICS INC - ADDITIONAL 40MG/KG ADULT COHORT DEMONSTRATES INCREMENTAL EFFICACY FROM ADULT GALACTOSEMIA STUDY

* APPLIED THERAPEUTICS INC - DATA REINFORCES AT-007 FAVORABLE SAFETY AND EFFICACY PROFILE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below